These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
51 related articles for article (PubMed ID: 3223175)
1. Synthesis of insulin-like growth factor-II by embryonal carcinoma cell-derived differentiated cells. Shi WK Shi Yan Sheng Wu Xue Bao; 1988 Sep; 21(3):355-67. PubMed ID: 3223175 [No Abstract] [Full Text] [Related]
2. Production of insulin-like growth factor-II (MSA) by endoderm-like cells derived from embryonal carcinoma cells: possible mediator of embryonic cell growth. Nagarajan L; Anderson WB; Nissley SP; Rechler MM; Jetten AM J Cell Physiol; 1985 Aug; 124(2):199-206. PubMed ID: 4044654 [TBL] [Abstract][Full Text] [Related]
3. Possible autocrine/paracrine actions of insulin-like growth factors during embryonic development: expression and action of IGFs in undifferentiated P19 cells. Eicher DJ; Moats-Staats BM; Stiles AD; D'Ercole AJ Dev Genet; 1993; 14(3):194-203. PubMed ID: 8358865 [TBL] [Abstract][Full Text] [Related]
4. Effects of dietary retinoids upon growth and differentiation of tumors derived from several murine embryonal carcinoma cell lines. McCue PA; Thomas RS; Schroeder D; Gubler ML; Sherman MI Cancer Res; 1988 Jul; 48(13):3772-9. PubMed ID: 3378217 [TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor-II expression in carcinoma in colon cell lines: implications for autocrine actions. Guo YS; Jin GF; Townsend CM; Zhang T; Sheng HM; Beauchamp RD; Thompson JC J Am Coll Surg; 1995 Aug; 181(2):145-54. PubMed ID: 7627387 [TBL] [Abstract][Full Text] [Related]
6. [Changes in patterns of protein synthesis during retinoic acid induced-differentiation of F9-1 embryonal carcinoma cells]. Liu L; Jiang YQ Yi Chuan Xue Bao; 1988; 15(2):122-8. PubMed ID: 3273664 [No Abstract] [Full Text] [Related]
7. Potential role of IGFBPS in the regulation of the differentiation state of human colonic carcinoma cells. Pommier G; Garrouste F; el Atiq F; Marvaldi J; Remacle-Bonnet M Growth Regul; 1993 Mar; 3(1):80-2. PubMed ID: 7683541 [No Abstract] [Full Text] [Related]
8. IGFBP-2: an important regulator of insulin-like growth factor action in human lung tumours? Reeve JG; Schwander J; Bleehen NM Growth Regul; 1993 Mar; 3(1):82-4. PubMed ID: 7683542 [No Abstract] [Full Text] [Related]
9. Expression of insulin-like growth factor-II and insulin-like growth factor binding proteins during Caco-2 cell proliferation and differentiation. Park JH; Corkins MR; Vanderhoof JA; Caruso NM; Hrbek MJ; Schaffer BS; Slentz DH; McCusker RH; MacDonald RG J Cell Physiol; 1996 Feb; 166(2):396-406. PubMed ID: 8592000 [TBL] [Abstract][Full Text] [Related]
10. Soluble insulin-like growth factor II/mannose 6-phosphate receptor inhibits DNA synthesis in insulin-like growth factor II sensitive cells. Scott CD; Weiss J J Cell Physiol; 2000 Jan; 182(1):62-8. PubMed ID: 10567917 [TBL] [Abstract][Full Text] [Related]
11. Expression of insulin-like growth factor II in spontaneously immortalized rat mesothelial and spontaneous mesothelioma cells: a potential autocrine role of insulin-like growth factor II. Rutten AA; Bermudez E; Stewart W; Everitt JI; Walker CL Cancer Res; 1995 Aug; 55(16):3634-9. PubMed ID: 7627973 [TBL] [Abstract][Full Text] [Related]
12. Alteration of the insulin-like growth factor axis during in vitro differentiation of the human osteosarcoma cell line HOS 58. Viereck V; Siggelkow H; Pannem R; Braulke T; Scharf JG; Kübler B J Cell Biochem; 2007 Sep; 102(1):28-40. PubMed ID: 17372931 [TBL] [Abstract][Full Text] [Related]
14. Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors. Reeve JG; Morgan J; Schwander J; Bleehen NM Cancer Res; 1993 Oct; 53(19):4680-5. PubMed ID: 7691401 [TBL] [Abstract][Full Text] [Related]
15. Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2. Differentiation in vivo and in vitro. Andrews PW; Damjanov I; Simon D; Banting GS; Carlin C; Dracopoli NC; Føgh J Lab Invest; 1984 Feb; 50(2):147-62. PubMed ID: 6694356 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of proliferation in human MNNG/HOS osteosarcoma and SK-ES-1 Ewing sarcoma cell lines in vitro and in vivo by antagonists of growth hormone-releasing hormone: effects on insulin-like growth factor II. Braczkowski R; Schally AV; Plonowski A; Varga JL; Groot K; Krupa M; Armatis P Cancer; 2002 Oct; 95(8):1735-45. PubMed ID: 12365022 [TBL] [Abstract][Full Text] [Related]
17. Expression of insulin-like growth factor (IGF)-II and IGF-I receptor during proliferation and differentiation of CaCo-2 human colon carcinoma cells. Zarrilli R; Pignata S; Romano M; Gravina A; Casola S; Bruni CB; Acquaviva AM Cell Growth Differ; 1994 Oct; 5(10):1085-91. PubMed ID: 7848910 [TBL] [Abstract][Full Text] [Related]
18. Loss of imprinting of the insulin-like growth factor II gene in mouse hepatocellular carcinoma cell lines. Ooasa T; Karasaki H; Kanda H; Nomura K; Kitagawa T; Ogawa K Mol Carcinog; 1998 Dec; 23(4):248-53. PubMed ID: 9869454 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of insulin-like growth factor-II in mouse embryonic stem cells promotes myogenic differentiation. Prelle K; Wobus AM; Krebs O; Blum WF; Wolf E Biochem Biophys Res Commun; 2000 Nov; 277(3):631-8. PubMed ID: 11062005 [TBL] [Abstract][Full Text] [Related]
20. IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human cells in vitro. Bendall SC; Stewart MH; Menendez P; George D; Vijayaragavan K; Werbowetski-Ogilvie T; Ramos-Mejia V; Rouleau A; Yang J; Bossé M; Lajoie G; Bhatia M Nature; 2007 Aug; 448(7157):1015-21. PubMed ID: 17625568 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]